KLEMANN, Christian, FUCHS, Ilka, ROHR, Jan, KREMENS, Bernhard, GOLDACKER, Sigune, SPECKMANN, Carsten, EHL, Stephan, RENSING-EHL, Anne und NEVEN, Benedicte, 2020. Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome. Freiburg: Universität.
Elsevier - Harvard (with titles)Klemann, C., Fuchs, I., Rohr, J., Kremens, B., Goldacker, S., Speckmann, C., Ehl, S., Rensing-Ehl, A., Neven, B., 2020. Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome. Universität, Freiburg. https://doi.org/10.3324/haematol.2016.153411
American Psychological Association 7th editionKlemann, C., Fuchs, I., Rohr, J., Kremens, B., Goldacker, S., Speckmann, C., Ehl, S., Rensing-Ehl, A., & Neven, B. (ca. 2020). Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome [Cd]. Universität. https://doi.org/10.3324/haematol.2016.153411
Springer - Basic (author-date)Klemann C, Fuchs I, Rohr J, Kremens B, Goldacker S, Speckmann C, Ehl S, Rensing-Ehl A, Neven B (2020) Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Klemann, Christian/ Fuchs, Ilka/ Rohr, Jan/ Kremens, Bernhard/ Goldacker, Sigune/ Speckmann, Carsten/ Ehl, Stephan/ Rensing-Ehl, Anne/ Neven, Benedicte, Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome, Freiburg 2020.